Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Phase 4

Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients with Ventriculitis

NCT06151392 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 4
Started
2023-07-01
Last updated
2025-02-25

Condition(s) studied

Ventriculitis, Infectious

Investigational drug(s) / intervention(s)

Probiotic FormulaZinc

Probiotic Formula: probiotic will be administered to pediatric patients with ventriculitis to study their possible effect in treatment

Zinc: Zinc will be administered to pediatric patients with ventriculitis to study their possible effect in treatment

Study summary

The aim of the study is to evaluate the effect of non-antibiotic-based supplemental interventions in the management of ventriculitis among pediatric patients.

The study objective is to detect the efficacy of probiotics and zinc when taken simultaneously with antibiotic treatment as immunomodulatory in increasing the recovery rate in pediatric population affected with ventriculitis.

Eligibility

Sex
ALL
Min age
1 Month
Max age
4 Years
Healthy volunteers
No
Inclusion Criteria: • Pediatric patients admitted to neurosurgery department with the diagnosis of ventriculitis will be enrolled in the study. Exclusion Criteria: * Patients suffering from any comorbidities other than ventriculitis such as cardiovascular, autoimmune diseases. etc . * Patients with allergy to zinc. * Patients with allergy to probiotics.

Primary outcome measure(s)

  • CSF culture — after 14 days of treatment
    time-to-event of negative CSF culture .
  • normalization of the CSF chemistry — after 14 days of treatment
    including normal CSF protein and normal CSF glucose levels
  • safety of probiotic and zinc supplementation — through study completion, an average of 1 year
    Number of participants with treatment-related adverse events

Trial sites (1)

FacilityCityRegionStatus
Ain shams university Cairo Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06151392 on ClinicalTrials.gov ↗ ← All trials in Egypt